INNOVATIONS in ONCOLOGICAL TREATMENTS and TUMOR MARKERS

Dear Colleagues,


The 40th ISOBM Anniversary Congress will take place in Jerusalem, Israel,

October 13- 17, 2012.

On behalf of the ISOBM Board and the Organizing Committee of our 40th ISOBM Anniversary Congress, we are pleased to invite you to participate actively at this Congress.


We anticipate a highly successful and exciting Congress focusing on basic, translational and clinical Cancer Research. Participants will have the opportunity to present and discuss their data, exchange ideas and expertise in an international framework, meet and network with colleagues from around the world and listen to lectures delivered by prominent Opinion Leaders in the Cancer field.

With your participation, contribution and activity, we hope to cover the full range of innovations in Cancer Diagnostics, BioMarkers and Cancer Therapy (new approaches as Small Molecules, Therapeutic Antibodies, Immuno-therapeutics, Large Biomolecules, etc.), to facilitate discussion and collaboration between early stage companies that are developing innovative products and technologies – all will contribute to a most successful meeting.

We will offer most interesting presentations by Invited Opinion Leaders, as well as Oral Presentations or Poster Sessions to be selected from the submitted Abstracts, Clinical Workshops and Round Tables.

The congress city, Jerusalem, situated high in the Judean Hills, is one of the most extraordinary cities in the world, established 3000 years ago by King David.
Jerusalem presents a unique combination of ancient history, spiritual sanctity and colorful cultures. Jerusalem is a fascinating city of many contrasts and diversities. It is a city where old and new, holy and secular, pure nature and beautiful architecture mix into magical harmony of smells, sounds and sights.
Sacred to the world's three main monotheistic religions, Jerusalem is a captivating city, whose visitors are left touched and inspired by the shining glow of its religious shrines of Judaism, Christianity and Islam, picturesque scenery and magnificent golden limestone.
Jerusalem is also the Capital of Israel, home to the Israeli Parliament (Knesset), the President's Residence and the Government offices.

We hope that you will be able to accept our invitation and participate in what promises to be a most important and stimulating Congress, as well as a memorable visit to Jerusalem- a truly worthwhile experience.
+ show speakers and program
FIDLER J.






Dept. of Cancer Biology,
R.E."Bob" Smith Distinguished Chair in Cell Biology
M. D. Anderson Cancer Center, Houston, TX,




USA





KRIPKE M.










Vivian L. Smith Professor and Chair Emerita,
Department of Immunology, The University of Texas,
M. D. Anderson Cancer Center, Houston, TX,
Member, USA President's Cancer Panel




USA





LEVITZKI A.




Unit of Cellular Signaling
Department of Biological Chemistry
The Hebrew University of Jerusalem




ISRAEL



SIDRANSKY D.






Director, Head and Neck Cancer Research
Johns Hopkins Medical Institutions

Past Director, AACR




USA





YARDEN Y.




Department of Biological Regulation,
Chair of Molecular Cell Biology,
The Weizmann Institute of Science
Chairman of ICA's Research Committee

ISRAEL







ADMON A. BIOLOGY DEPT. TECHNION HAIFA ISRAEL
AMITAL H. SHEBA MEDICAL CENTER TEL AVIV ISRAEL
APTE R. BEN- GURION UNIVERSITY BEER SHEVA ISRAEL
ARLEN M. NORTH SHOR UNIVERSITY HOSPITAL USA
ARBER N. TEL AVIV SOURASKY MEDICAL CENTER ISRAEL
BARAK V. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
BAR-SHAVIT R. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
BANIASH M. HEBREW UNIVERSITY, SCHOOL of MEDICINE JERUSALEM ISRAEL
BEAUCHEMIN N. GOODMAN CANCER RESERCH CENTER McGill Uni. CANADA
BEN - BARUCH N. KAPLAN MEDICAL CENTER REHOVOT ISRAEL
BIRKENFELD S. TEL AVIV UNIVERSITY ISRAEL
CHAPMAN C. NOTTINGHAM CITY HOSPITAL UK
CZERNINSKI R. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
DIAMANDIS E. MOUNT SINAI HOSPITAL & UNIVERSITY of TORONTO CANADA
DUFFY J. St. VINCENT'S UNIVERSITY HOSPITAL IRELAND
EDELMAN D. CENTER FOR CANCER RESERCH, NCI, NIH. USA
FIBACH E. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
FRIDLENDER Z. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
FRITSCHE A. H. MD ANDERSON CANCER CENTER, HOUSTON, TX USA
GORODETSKY R. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
GION M. REGIONAL GENERAL HOSPITAL, VENICE ITALY
HAICK H. CHEM. ENG. & NANOTECHNOLOGY INST., TECHNION ISRAEL
HAIMOVITZ- FRIDMAN A. MEMORIAL SLOAN KETTERING CANCER CENTER USA
HOLDENRIEDER S. UNIVERSITY HOSPITAL BONN GERMANY
HUBERT A. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
KAUFMAN B. SHEBA MEDICAL CENTER TEL AVIV ISRAEL
KEISARY Y. TEL AVIV UNIVERSITY ISRAEL
LAMERZ R. UNIVERSITY OF MUNCHEN GERMANY
MARKEL G. SHEBA MEDICAL CENTER TEL AVIV ISRAEL
MEIROVITZ A. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
MERIMS S. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
MOLINA R. HOSPITAL CLINIC BARCELONA SPAIN
MORDECHAI S. BEN- GURION UNIVERSITY BEER SHEVA ISRAEL
MORO R. BIO CUREX CANADA
O'BRIEN T. UNIVERSITY of ARKANSAS for MEDICAL SCIENCES USA
NAP M. CLINICAL PATHOLOGY, ATRIUM HEERLEN HOLLAND
NEHUSHTAN H. HADASSAH MEDICAL CENTER JERUSALEM ISRAEL
NICOLINI A. UNIVERSITY HOSPITAL PISA ITALY
PAUS E. CENTRAL LABORATORY, OSLO NORWAY
RADOSEVICH J. UNIVERSITY of ILLINOIS at CHICAGO USA
ROBOOL M.J. DEPT. of UROLOGY, ERASMUS M.C. ROTTERDAM HOLLAND
SANCHEZ- CARBAYO M. SPANISH NATIONAL CANCER RESERCH CENTER SPAIN
SELL S. WADSWORTH CENTER, UNIVERSITY of PITTSBURGH USA
SEMJONOW A. UNIVERSITY CLINIC - PROSTATE CENTER, MUNSTER GERMANY
SHOENFELD Y. SHEBA MEDICAL CENTER TEL AVIV ISRAEL
SOLETORMOS G. CLINICAL BIOCHEMISTRY HILLERED UNI.HOSPITAL DENMARK
STENMAN U.H. CENTRAL HOSPITAL HELSINKI UNIVERSITY FINLAND
STIEBER P. UNIVERSITY OF MUNCHEN GERMANY
TOPOLCAN O. 2 DEPT. of MEDICINE, UNIVERSITY HOSPITAL, PILSEN CZECH REPUBLIC
TREVES A. SHEBA MEDICAL CENTER ISRAEL
VLODAVSKY I. FACULTY OF MEDICINE, TECHNION HAIFA ISRAEL
ZIMA T. CHARLES UNIVERSITY & GENERAL HOSPITAL, PRAGUE CZECH REP

13 Oct - 17 Oct 2012
Jerusalem
Israel
meeting website